Fleqsuvy™(baclofen) – New drug approval
February 7, 2022 - Azurity Pharmaceuticals announced the FDA approval of Fleqsuvy (baclofen) oral suspension, for the treatment of spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity.
Top